Who
Lou Silverman
Director
Company insider
Files Form 4 as: Director, Insight Molecular Diagnostics; Director, STAAR Surgical; Director, Veradigm; Director, Comarco; Director, Questcor Pharmaceuticals; Chief Executive Officer, Quality Systems.
In numbers
- Trades disclosed
- 112
- Buys
- 1
- Sells
- 5
- Bought
- $12K
- Sold
- $11.0M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 12 Jun 2007
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $44K7,700 at $5.69 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $44K7,700 at $5.69 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —10,683 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —10,683 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —6,182 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —10,683 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —6,182 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —10,683 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —26,943 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —26,943 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | VeradigmIT Services & Consulting | SEC FORM 4 Code A | —42,507 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | Veradigm | SEC FORM 4 Code A | —42,507 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 18 Jun 2025filed 20 Jun 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —10,683 at $0.00 | filing |
| 2 Jun 2025filed 3 Jun 2025 | Veradigm | SEC FORM 4 Code A | $200K46,512 at $4.30 | filing |
| 12 May 2025filed 13 May 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —2,440 at $0.00 | filing |
| 24 Mar 2025filed 26 Mar 2025 | Veradigm | SEC FORM 4 Code A | —10,112 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Jun 2023filed 27 Jun 2023 | IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —112,500 at $0.00 | filing |
| 23 Jun 2023filed 27 Jun 2023 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuySTAA · themarketsdaily.com · 12 Oct 2026STAAR Surgical (NASDAQ:STAA) vs. Sensus Healthcare (NASDAQ:SRTS) Head to Head SurveySTAA · tickerreport.com · 6 Oct 2026
0 headlines in the last 90 days name Lou Silverman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.